Document:

EX 10.1 Sabra_2009_Performance_Incentive_Plan

SABRA HEALTH CARE REIT, INC.
2009 PERFORMANCE INCENTIVE PLAN

(Effective April 2, 2014)

1.  PURPOSE OF PLAN
The purpose of this Sabra Health Care REIT, Inc. 2009 Performance Incentive Plan (this “Plan”) of Sabra Health Care REIT, Inc., a Maryland corporation (the “Corporation”), is to promote the success of the Corporation and to increase stockholder value by providing an additional means through the grant of awards to attract, motivate, retain and reward selected employees and other eligible persons.
2.      ELIGIBILITY
The Administrator (as such term is defined in Section 3.1) may grant awards under this Plan only to those persons that the Administrator determines to be Eligible Persons.  An “Eligible Person” is any person who is either:  (a) an officer (whether or not a director) or employee of the Corporation or one of its Subsidiaries; (b) a director of the Corporation or one of its Subsidiaries; or (c) an individual consultant or advisor who renders or has rendered bona fide services (other than services in connection with the offering or sale of securities of the Corporation or one of its Subsidiaries in a capital-raising transaction or as a market maker or promoter of securities of the Corporation or one of its Subsidiaries) to the Corporation or one of its Subsidiaries and who is selected to participate in this Plan by the Administrator; provided, however, that a person who is otherwise an Eligible Person under clause (c) above may participate in this Plan only if such participation would not adversely affect either the Corporation’s eligibility to use Form S-8 to register under the Securities Act of 1933, as amended (the “Securities Act”), the offering and sale of shares issuable under this Plan by the Corporation or the Corporation’s compliance with any other applicable laws.  An Eligible Person who has been granted an award (a “participant”) may, if otherwise eligible, be granted additional awards if the Administrator shall so determine.  As used herein, “Subsidiary” means any corporation or other entity a majority of whose outstanding voting stock or voting power is beneficially owned directly or indirectly by the Corporation; and “Board” means the Board of Directors of the Corporation.

3.      PLAN ADMINISTRATION
		
	3.1
	The Administrator.  This Plan shall be administered by and all awards under this Plan shall be authorized by the Administrator.  The “Administrator” means the Board or one or more committees appointed by the Board or another committee (within its delegated authority) to administer all or certain aspects of this Plan.  Any such committee shall be comprised solely of one or more directors or such number of directors as may be required under applicable law.  A committee may delegate some or all of its authority to another committee so constituted.  The Board or a committee comprised solely of directors may also delegate, to the extent permitted by the Maryland General Corporation Law and any other applicable law, to one or more officers of the Corporation, its powers under this Plan (a) to designate the officers and employees of the Corporation and its Subsidiaries who will receive grants of awards under this Plan, and (b) to determine the number of shares subject to, and the other terms and conditions of, such awards.  The Board may delegate different levels of authority to different committees with administrative and grant authority under this Plan.  Unless otherwise provided in the Bylaws of the Corporation or the applicable charter of any Administrator: (a) a majority of the members of the acting Administrator shall constitute a quorum, and (b) the vote of a majority of the members present assuming the presence of a quorum or the unanimous written consent of the members of the Administrator shall constitute action by the acting Administrator.

With respect to awards intended to satisfy the requirements for performance-based compensation under Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”), this Plan shall be administered by a committee consisting solely of two or more outside directors (as this requirement is applied under Section 162(m) of the Code); provided, however, that the failure to satisfy such requirement shall not affect the validity of the action of any committee otherwise duly authorized and acting in the matter.  Award grants, and transactions in or involving awards, intended to be exempt under Rule 16b-3 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), must be duly and timely authorized by the Board or a committee consisting solely of two or more non-employee directors (as this requirement is applied under Rule 16b-3 promulgated under the Exchange Act).  To the extent required by any applicable listing agency, this Plan shall be administered by a committee composed entirely of independent directors (within the meaning of the applicable listing agency).

1

		
	3.2
	Powers of the Administrator.  Subject to the express provisions of this Plan, the Administrator is authorized and empowered to do all things necessary or desirable in connection with the authorization of awards and the administration of this Plan (in the case of a committee or delegation to one or more officers, within the authority delegated to that committee or person(s)), including, without limitation, the authority to:

		
	(a)
	determine eligibility and, from among those persons determined to be eligible, the particular Eligible Persons who will receive an award under this Plan;

		
	(b)
	grant awards to Eligible Persons, determine the price at which securities will be offered or awarded and the number of securities to be offered or awarded to any of such persons, determine the other specific terms and conditions of such awards consistent with the express limits of this Plan, establish the installments (if any) in which such awards shall become exercisable or shall vest (which may include, without limitation, performance and/or time-based schedules), or determine that no delayed exercisability or vesting is required, establish any applicable performance targets, and establish the events of termination or reversion of such awards;

		
	(c)
	approve the forms of award agreements (which need not be identical either as to type of award or among participants);

		
	(d)
	construe and interpret this Plan and any agreements defining the rights and obligations of the Corporation, its Subsidiaries, and participants under this Plan, further define the terms used in this Plan, and prescribe, amend and rescind rules and regulations relating to the administration of this Plan or the awards granted under this Plan;

		
	(e)
	cancel, modify, or waive the Corporation’s rights with respect to, or modify, discontinue, suspend, or terminate any or all outstanding awards, subject to any required consent under Section 8.6.5;

		
	(f)
	accelerate or extend the vesting or exercisability or extend the term of any or all such outstanding awards (in the case of options or stock appreciation rights, within the maximum seven-year term of such awards) in such circumstances as the Administrator may deem appropriate (including, without limitation, in connection with a termination of employment or services or other events of a personal nature) subject to any required consent under Section 8.6.5;

		
	(g)
	adjust the number of shares of Common Stock subject to any award, adjust the price of any or all outstanding awards or otherwise change previously imposed terms and conditions, in such circumstances as the Administrator may deem appropriate, in each case subject to Sections 4 and 8.6 (subject to the no repricing provision below);

		
	(h)
	determine the date of grant of an award, which may be a designated date after but not before the date of the Administrator’s action (unless otherwise designated by the Administrator, the date of grant of an award shall be the date upon which the Administrator took the action granting an award);

		
	(i)
	determine whether, and the extent to which, adjustments are required pursuant to Section 7 hereof and authorize the termination, conversion, substitution or succession of awards upon the occurrence of an event of the type described in Section 7;

		
	(j)
	acquire or settle (subject to Sections 7 and 8.6) rights under awards in cash, stock of equivalent value, or other consideration (subject to the no repricing provision below); and

		
	(k)
	determine the fair market value of the Common Stock or awards under this Plan from time to time and/or the manner in which such value will be determined.

Notwithstanding the foregoing and except for an adjustment pursuant to Section 7.1 or a repricing approved by stockholders, in no case may the Administrator (1) amend an outstanding stock option or SAR to reduce the exercise price or base price of the award, (2) cancel, exchange, or surrender an outstanding stock option or SAR in exchange for cash or other awards for the purpose of repricing the award, or (3) cancel, exchange, or surrender an outstanding stock option or SAR in exchange for an option or SAR with an exercise or base price that is less than the exercise or base price of the original award.

2

 

		
	3.3
	Binding Determinations.  Any action taken by, or inaction of, the Corporation, any Subsidiary, or the Administrator relating or pursuant to this Plan and within its authority hereunder or under applicable law shall be within the absolute discretion of that entity or body and shall be conclusive and binding upon all persons.  Neither the Board nor any Board committee, nor any member thereof or person acting at the direction thereof, shall be liable for any act, omission, interpretation, construction or determination made in good faith in connection with this Plan (or any award made under this Plan), and all such persons shall be entitled to indemnification and reimbursement by the Corporation in respect of any claim, loss, damage or expense (including, without limitation, attorneys’ fees) arising or resulting therefrom to the fullest extent permitted by law and/or under any directors and officers liability insurance coverage that may be in effect from time to time.

		
	3.4
	Reliance on Experts.  In making any determination or in taking or not taking any action under this Plan, the Administrator may obtain and may rely upon the advice of experts, including employees and professional advisors to the Corporation.  No director, officer or agent of the Corporation or any of its Subsidiaries shall be liable for any such action or determination taken or made or omitted in good faith.

		
	3.5
	Delegation.  The Administrator may delegate ministerial, non-discretionary functions to individuals who are officers or employees of the Corporation or any of its Subsidiaries or to third parties.

4.      SHARES OF COMMON STOCK SUBJECT TO THE PLAN; SHARE LIMITS
		
	4.1
	Shares Available.  Subject to the provisions of Section 7.1, the capital stock that may be delivered under this Plan shall be shares of the Corporation’s authorized but unissued Common Stock and any shares of its Common Stock held as treasury shares.  For purposes of this Plan, “Common Stock” shall mean the common stock of the Corporation and such other securities or property as may become the subject of awards under this Plan, or may become subject to such awards, pursuant to an adjustment made under Section 7.1.

		
	4.2
	Share Limits.  The maximum number of shares of Common Stock that may be delivered pursuant to awards granted to Eligible Persons under this Plan (the “Share Limit”) is equal to 3,840,595.

Shares issued in respect of any “Full-Value Award” granted under this Plan shall be counted against the foregoing Share Limit as 1.25 shares for every one share actually issued in connection with such award.  (For example, if a stock bonus of 100 shares of Common Stock is granted under this Plan, 125 shares shall be charged against the Share Limit in connection with that award.)  For this purpose, a “Full-Value Award” means any award under this Plan that is  not  a stock option grant or a stock appreciation right grant.
The following limits also apply with respect to awards granted under this Plan:
		
	(a)
	The maximum number of shares of Common Stock that may be delivered pursuant to options qualified as incentive stock options granted under this Plan is 2,000,000 shares.

		
	(b)
	The maximum number of shares of Common Stock subject to those options and stock appreciation rights that are granted during any calendar year to any individual under this Plan is 333,333 shares.

		
	(c)
	Additional limits with respect to Performance-Based Awards are set forth in Section 5.2.3.

Each of the foregoing numerical limits is subject to adjustment as contemplated by Section 4.3, Section 7.1, and Section 8.10.
		
	4.3
	Awards Settled in Cash, Reissue of Awards and Shares.  Except as provided in the next sentence, shares that are subject to or underlie awards granted under this Plan which expire or for any reason are cancelled or terminated, are forfeited, fail to vest, or for any other reason are not paid or delivered under this Plan shall again be available for subsequent awards under this Plan.  Shares that are exchanged by a participant or withheld by the Corporation as full or partial payment in connection with any stock option or stock appreciation right granted under this Plan, as well as any shares exchanged by a participant or withheld by the Corporation or one of its Subsidiaries to satisfy the tax withholding obligations related to any stock option or stock appreciation right granted under this Plan, shall not be available for subsequent awards under this Plan.  After December 31, 2013, shares that are exchanged by a participant or withheld by the Corporation as full or partial payment in connection with any Full-Value Award granted under this Plan, as well as any shares 

3

 

exchanged by a participant or withheld by the Corporation or one of its Subsidiaries to satisfy the tax withholding obligations related to any Full-Value Award granted under this Plan, shall be available for subsequent awards under this Plan, provided that any one (1) share so exchanged or withheld in connection with any Full-Value Award shall be credited as 1.25 shares when determining the number of shares that shall again become available for subsequent awards under this Plan if, upon grant, the shares underlying the related Full-Value Award were counted as 1.25 shares against the Share Limit.  To the extent that an award granted under this Plan is settled in cash or a form other than shares of Common Stock, the shares that would have been delivered had there been no such cash or other settlement shall not be counted against the shares available for issuance under this Plan.  In the event that shares of Common Stock are delivered in respect of a dividend equivalent right granted under this Plan, the number of shares delivered with respect to the award shall be counted against the share limits of this Plan (including, for purposes of clarity, the limits of Section 4.2 of this Plan).  (For purposes of clarity, if 1,000 dividend equivalent rights are granted and outstanding when the Corporation pays a dividend, and 50 shares are delivered in payment of those rights with respect to that dividend, 62.5 shares (after giving effect to the Full-Value Award premium counting rules) shall be counted against the share limits of this Plan).  To the extent that shares of Common Stock are delivered pursuant to the exercise of a stock appreciation right or stock option granted under this Plan, the number of underlying shares as to which the exercise related shall be counted against the applicable share limits under Section 4.2, as opposed to only counting the shares actually issued.  (For purposes of clarity, if a stock appreciation right relates to 100,000 shares and is exercised at a time when the payment due to the participant is 15,000 shares, 100,000 shares shall be charged against the applicable share limits under Section 4.2 with respect to such exercise.)  Refer to Section 8.10 for application of the foregoing share limits with respect to assumed awards.  The foregoing adjustments to the share limits of this Plan are subject to any applicable limitations under Section 162(m) of the Code with respect to awards intended as performance-based compensation thereunder.
		
	4.4
	Reservation of Shares; No Fractional Shares; Minimum Issue.  The Corporation shall at all times reserve a number of shares of Common Stock sufficient to cover the Corporation’s obligations and contingent obligations to deliver shares with respect to awards then outstanding under this Plan (exclusive of any dividend equivalent obligations to the extent the Corporation has the right to settle such rights in cash).  No fractional shares shall be delivered under this Plan.  The Administrator may pay cash in lieu of any fractional shares in settlements of awards under this Plan.  No fewer than 100 shares may be purchased on exercise of any award (or, in the case of stock appreciation or purchase rights, no fewer than 100 rights may be exercised at any one time) unless the total number purchased or exercised is the total number at the time available for purchase or exercise under the award.

5.      AWARDS
		
	5.1
	Type and Form of Awards.  The Administrator shall determine the type or types of award(s) to be made to each selected Eligible Person.  Awards may be granted singly, in combination or in tandem.  Awards also may be made in combination or in tandem with, in replacement of, as alternatives to, or as the payment form for grants or rights under any other employee or compensation plan of the Corporation or one of its Subsidiaries.  The types of awards that may be granted under this Plan are (subject, in each case, to the no repricing provisions of Section 3.2):

		
	5.1.1
	Stock Options.  A stock option is the grant of a right to purchase a specified number of shares of Common Stock during a specified period as determined by the Administrator.  An option may be intended as an incentive stock option within the meaning of Section 422 of the Code (an “ISO”) or a nonqualified stock option (an option not intended to be an ISO).  The award agreement for an option will indicate if the option is intended as an ISO; otherwise it will be deemed to be a nonqualified stock option.  The maximum term of each option (ISO or nonqualified) shall be seven (7) years.  The per share exercise price for each option shall be not less than 100% of the fair market value of a share of Common Stock on the date of grant of the option.  When an option is exercised, the exercise price for the shares to be purchased shall be paid in full in cash or such other method permitted by the Administrator consistent with Section 5.5.

		
	5.1.2
	Additional Rules Applicable to ISOs.  To the extent that the aggregate fair market value (determined at the time of grant of the applicable option) of stock with respect to which ISOs first become exercisable by a participant in any calendar year exceeds $100,000, taking into account both 

4

 

Common Stock subject to ISOs under this Plan and stock subject to ISOs under all other plans of the Corporation or one of its Subsidiaries (or any parent or predecessor corporation to the extent required by and within the meaning of Section 422 of the Code and the regulations promulgated thereunder), such options shall be treated as nonqualified stock options.  In reducing the number of options treated as ISOs to meet the $100,000 limit, the most recently granted options shall be reduced first.  To the extent a reduction of simultaneously granted options is necessary to meet the $100,000 limit, the Administrator may, in the manner and to the extent permitted by law, designate which shares of Common Stock are to be treated as shares acquired pursuant to the exercise of an ISO.  ISOs may only be granted to employees of the Corporation or one of its subsidiaries (for this purpose, the term “subsidiary” is used as defined in Section 424(f) of the Code, which generally requires an unbroken chain of ownership of at least 50% of the total combined voting power of all classes of stock of each subsidiary in the chain beginning with the Corporation and ending with the subsidiary in question).  There shall be imposed in any award agreement relating to ISOs such other terms and conditions as from time to time are required in order that the option be an “incentive stock option” as that term is defined in Section 422 of the Code.  No ISO may be granted to any person who, at the time the option is granted, owns (or is deemed to own under Section 424(d) of the Code) shares of outstanding Common Stock possessing more than 10% of the total combined voting power of all classes of stock of the Corporation, unless the exercise price of such option is at least 110% of the fair market value of the stock subject to the option and such option by its terms is not exercisable after the expiration of five years from the date such option is granted.
		
	5.1.3
	Stock Appreciation Rights.  A stock appreciation right or “SAR” is a right to receive a payment, in cash and/or Common Stock, equal to the excess of the fair market value of a specified number of shares of Common Stock on the date the SAR is exercised over the “base price” of the award, which base price shall be set forth in the applicable award agreement and shall be not less than 100% of the fair market value of a share of Common Stock on the date of grant of the SAR.  The maximum term of a SAR shall be seven (7) years.

		
	5.1.4
	Other Awards.  The other types of awards that may be granted under this Plan include: (a) stock bonuses, restricted stock, performance stock, stock units, phantom stock, dividend equivalents, or similar rights to purchase or acquire shares, whether at a fixed or variable price or ratio related to the Common Stock, upon the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any combination thereof; (b) any similar securities with a value derived from the value of or related to the Common Stock and/or returns thereon; or (c) cash awards.  Dividend equivalent rights may be granted as a separate award or in connection with another award under this Plan; provided, however, that dividend equivalent rights may not be granted in connection with a stock option or SAR granted under this Plan.  In addition, any dividends and/or dividend equivalents as to the unvested portion of a restricted stock award that is subject to performance-based vesting requirements or the unvested portion of a stock unit award that is subject to performance-based vesting requirements will be subject to termination and forfeiture to the same extent as the corresponding portion of the award to which they relate.

		
	5.2
	Section 162(m) Performance-Based Awards.  Without limiting the generality of the foregoing, any of the types of awards listed in Section 5.1.4 above may be, and options and SARs granted to officers and employees (“Qualifying Options” and “Qualifying SARS,” respectively) typically will be, granted as awards intended to satisfy the requirements for “performance-based compensation” within the meaning of Section 162(m) of the Code (“Performance-Based Awards”).  The grant, vesting, exercisability or payment of Performance-Based Awards may depend (or, in the case of Qualifying Options or Qualifying SARs, may also depend) on the degree of achievement of one or more performance goals relative to a pre-established targeted level or levels using one or more of the Business Criteria set forth below (on an absolute basis or relative to the performance of other companies or upon comparisons of any of the indicators of performance relative to other companies) for the Corporation on a consolidated basis or for one or more of the Corporation’s subsidiaries, segments, divisions or business units, or any combination of the foregoing.  Any Qualifying Option or Qualifying SAR shall be subject only to the requirements of Section 5.2.1 and 5.2.3 in order for such award to satisfy the requirements for “performance-based compensation” under Section 162(m) of the Code.  Any other Performance-Based Award shall be subject to all of the following provisions of this Section 5.2.

5

 

		
	5.2.1
	Class; Administrator.  The eligible class of persons for Performance-Based Awards under this Section 5.2 shall be officers and employees of the Corporation or one of its Subsidiaries.  The Administrator approving Performance-Based Awards or making any certification required pursuant to Section 5.2.4 must be constituted as provided in Section 3.1 for awards that are intended as performance-based compensation under Section 162(m) of the Code.

		
	5.2.2
	Performance Goals.  The specific performance goals for Performance-Based Awards (other than Qualifying Options and Qualifying SARs) shall be, on an absolute or relative basis, established based on one or more of the following business criteria (“Business Criteria”) as selected by the Administrator in its sole discretion:  earnings per share; cash flow (which means cash and cash equivalents derived from either net cash flow from operations or net cash flow from operations, financing and investing activities); stock price; total stockholder return; gross revenue; revenue growth; operating income (before or after taxes); net earnings (before or after interest, taxes, depreciation and/or amortization); return on equity or on assets or on net investment; net revenue growth; market share; planning accuracy (as measured by comparing planned results to actual results); net revenue; earnings before interest, taxes, depreciation, amortization (EBITDA); pre- or after-tax income (before or after allocation of corporate overhead and bonus); appreciation in and/or maintenance of the price of the Common Stock or any other publicly-traded securities of the Corporation; gross profits; economic value-added models or equivalent metrics; comparisons with various stock market indices; cash flow per share (before or after dividends); return on capital (including return on total capital or return on invested capital); cash flow return on investment; stockholder equity; strategic partnerships or transactions; financial ratios, including those measuring liquidity, activity, profitability or leverage; cost of capital or assets under management; financing and other capital raising transactions (including sales of the Corporation’s equity or debt securities); implementation, completion or attainment of measurable objectives with respect to acquisitions and divestitures and recruiting and maintaining personnel; funds from operations or adjusted funds from operations (each on an aggregate or per share basis); or any combination thereof.  These terms are used as applied under generally accepted accounting principles or in the financial reporting of the Corporation or of its Subsidiaries.  To qualify awards as performance-based under Section 162(m), the applicable Business Criterion (or Business Criteria, as the case may be) and specific performance goal or goals (“targets”) must be established and approved by the Administrator during the first 90 days of the performance period (and, in the case of performance periods of less than one year, in no event after 25% or more of the performance period has elapsed) and while performance relating to such target(s) remains substantially uncertain within the meaning of Section 162(m) of the Code.  The terms of the Performance-Based Award may specify the manner, if any, in which performance targets shall be adjusted to mitigate the unbudgeted impact of material, unusual or nonrecurring gains and losses, accounting changes or other extraordinary events not foreseen at the time the targets were set unless the Administrator provides otherwise at the time of establishing the targets.  The applicable performance measurement period may not be less than three months nor more than 10 years.

		
	5.2.3
	Form of Payment; Maximum Performance-Based Award.  Grants or awards under this Section 5.2 may be paid in cash or shares of Common Stock or any combination thereof.  Grants of Qualifying Options and Qualifying SARs to any one participant in any one calendar year shall be subject to the limit set forth in Section 4.2(b).  The maximum number of shares of Common Stock which may be delivered pursuant to Performance-Based Awards (other than Qualifying Options and Qualifying SARs, and other than cash awards covered by the following sentence) that are granted to any one participant in any one calendar year shall not exceed 333,333 shares (counting such shares on a one for one basis for this purpose), either individually or in the aggregate, subject to adjustment as provided in Section 7.1.  In addition, the aggregate amount of compensation to be paid to any one participant in respect of all Performance-Based Awards payable only in cash and not related to shares of Common Stock and granted to that participant in any one calendar year shall not exceed $5,000,000.  Awards that are cancelled during the year shall be counted against these limits to the extent required by Section 162(m) of the Code.

		
	5.2.4
	Certification of Payment.  Before any Performance-Based Award under this Section 5.2 (other than Qualifying Options and Qualifying SARs) is paid and to the extent required to qualify the award as performance-based compensation within the meaning of Section 162(m) of the Code, the 

6

 

Administrator must certify in writing that the performance target(s) and any other material terms of the Performance-Based Award were in fact timely satisfied.
		
	5.2.5
	Reservation of Discretion.  The Administrator will have the discretion to determine the restrictions or other limitations of the individual awards granted under this Section 5.2 including the authority to reduce awards, payouts or vesting or to pay no awards, in its sole discretion, if the Administrator preserves such authority at the time of grant by language to this effect in its authorizing resolutions or otherwise.

		
	5.2.6
	Expiration of Grant Authority.  As required pursuant to Section 162(m) of the Code and the regulations promulgated thereunder, the Administrator’s authority to grant new awards that are intended to qualify as performance-based compensation within the meaning of Section 162(m) of the Code (other than Qualifying Options and Qualifying SARs) shall terminate upon the first meeting of the Corporation’s stockholders that occurs in the fifth year following the last year in which the Corporation’s stockholders most recently approved this Plan, subject to any subsequent extension that may be approved by stockholders.

		
	5.3
	Award Agreements.  Each award shall be evidenced by either (1) a written award agreement in a form approved by the Administrator and executed by the Corporation by an officer duly authorized to act on its behalf, or (2) an electronic notice of award grant in a form approved by the Administrator and recorded by the Corporation (or its designee) in an electronic recordkeeping system used for the purpose of tracking award grants under this Plan generally (in each case, an “award agreement”), as the Administrator may provide and, in each case and if required by the Administrator, executed or otherwise electronically accepted by the recipient of the award in such form and manner as the Administrator may require.  The Administrator may authorize any officer of the Corporation (other than the particular award recipient) to execute any or all award agreements on behalf of the Corporation.  The award agreement shall set forth the material terms and conditions of the award as established by the Administrator consistent with the express limitations of this Plan.

		
	5.4
	Deferrals and Settlements.  Payment of awards may be in the form of cash, Common Stock, other awards or combinations thereof as the Administrator shall determine, and with such restrictions as it may impose.  The Administrator may also require or permit participants to elect to defer the issuance of shares or the settlement of awards in cash under such rules and procedures as it may establish under this Plan.  The Administrator may also provide that deferred settlements include the payment or crediting of interest or other earnings on the deferral amounts, or the payment or crediting of dividend equivalents where the deferred amounts are denominated in shares.

		
	5.5
	Consideration for Common Stock or Awards.  The purchase price for any award granted under this Plan or the Common Stock to be delivered pursuant to an award, as applicable, may be paid by means of any lawful consideration as determined by the Administrator, including, without limitation, one or a combination of the following methods:

		
	•
	services rendered by the recipient of such award;

		
	•
	cash, check payable to the order of the Corporation, or electronic funds transfer;

		
	•
	notice and third party payment in such manner as may be authorized by the Administrator;

		
	•
	the delivery of previously owned shares of Common Stock;

		
	•
	by a reduction in the number of shares otherwise deliverable pursuant to the award; or

		
	•
	subject to such procedures as the Administrator may adopt, pursuant to a “cashless exercise” with a third party who provides financing for the purposes of (or who otherwise facilitates) the purchase or exercise of awards.

In no event shall any shares newly-issued by the Corporation be issued for less than the minimum lawful consideration for such shares or for consideration other than consideration permitted by applicable state law.  

7

 

Shares of Common Stock used to satisfy the exercise price of an option shall be valued at their fair market value on the date of exercise.  The Corporation will not be obligated to deliver any shares unless and until it receives full payment of the exercise or purchase price therefor and any related withholding obligations under Section 8.5 and any other conditions to exercise or purchase have been satisfied.  Unless otherwise expressly provided in the applicable award agreement, the Administrator may at any time eliminate or limit a participant’s ability to pay the purchase or exercise price of any award or shares by any method other than cash payment to the Corporation. 
		
	5.6
	Definition of Fair Market Value.  For purposes of this Plan, “fair market value” shall mean, unless otherwise determined or provided by the Administrator in the circumstances, the closing price (in regular trading) for a share of Common Stock as furnished by the National Association of Securities Dealers, Inc. (the “NASD”) through the NASDAQ Global Market Reporting System (the “Global Market”) for the date in question or, if no sales of Common Stock were reported by the NASD on the Global Market on that date, the last price (in regular trading) for a share of Common Stock as furnished by the NASD through the Global Market for the next preceding day on which sales of Common Stock were reported by the NASD.  The Administrator may, however, provide with respect to one or more awards that the fair market value shall equal the last price (in regular trading) for a share of Common Stock as furnished by the NASD through the Global Market on the last trading day preceding the date in question or the average of the high and low trading prices of a share of Common Stock as furnished by the NASD through the Global Market for the date in question or the most recent trading day.  If the Common Stock is no longer listed or is no longer actively traded on the Global Market as of the applicable date, the fair market value of the Common Stock shall be the value as reasonably determined by the Administrator for purposes of the award in the circumstances.  The Administrator also may adopt a different methodology for determining fair market value with respect to one or more awards if a different methodology is necessary or advisable to secure any intended favorable tax, legal or other treatment for the particular award(s) (for example, and without limitation, the Administrator may provide that fair market value for purposes of one or more awards will be based on an average of closing prices (or the average of high and low daily trading prices) for a specified period preceding the relevant date).

		
	5.7
	Transfer Restrictions.

		
	5.7.1
	Limitations on Exercise and Transfer.  Unless otherwise expressly provided in (or pursuant to) this Section 5.7 or required by applicable law: (a) all awards are non-transferable and shall not be subject in any manner to sale, transfer, anticipation, alienation, assignment, pledge, encumbrance or charge; (b) awards shall be exercised only by the participant; and (c) amounts payable or shares issuable pursuant to any award shall be delivered only to (or for the account of) the participant.

		
	5.7.2
	Exceptions.  The Administrator may permit awards to be exercised by and paid to, or otherwise transferred to, other persons or entities pursuant to such conditions and procedures, including limitations on subsequent transfers, as the Administrator may, in its sole discretion, establish in writing.  Any permitted transfer shall be subject to compliance with applicable federal and state securities laws and shall not be for value (other than nominal consideration, settlement of marital property rights, or for interests in an entity in which more than 50% of the voting interests are held by the Eligible Person or by the Eligible Person’s family members).

		
	5.7.3
	Further Exceptions to Limits on Transfer.  The exercise and transfer restrictions in Section 5.7.1 shall not apply to:

		
	(a)
	transfers to the Corporation (for example, in connection with the expiration or termination of the award),

		
	(b)
	the designation of a beneficiary to receive benefits in the event of the participant’s death or, if the participant has died, transfers to or exercise by the participant’s beneficiary, or, in the absence of a validly designated beneficiary, transfers by will or the laws of descent and distribution,

		
	(c)
	subject to any applicable limitations on ISOs, transfers to a family member (or former family member) pursuant to a domestic relations order if approved or ratified by the Administrator,

8

 

		
	(d)
	if the participant has suffered a disability, permitted transfers or exercises on behalf of the participant by his or her legal representative, or

		
	(e)
	the authorization by the Administrator of “cashless exercise” procedures with third parties who provide financing for the purpose of (or who otherwise facilitate) the exercise of awards consistent with applicable laws and the express authorization of the Administrator.

		
	5.8
	International Awards.  One or more awards may be granted to Eligible Persons who provide services to the Corporation or one of its Subsidiaries outside of the United States.  Any awards granted to such persons may be granted pursuant to the terms and conditions of any applicable sub-plans, if any, appended to this Plan and approved by the Administrator.

6.      EFFECT OF TERMINATION OF EMPLOYMENT OR SERVICE ON AWARDS
		
	6.1
	General.  The Administrator shall establish the effect of a termination of employment or service on the rights and benefits under each award under this Plan and in so doing may make distinctions based upon, inter alia, the cause of termination and type of award.  If the participant is not an employee of the Corporation or one of its Subsidiaries and provides other services to the Corporation or one of its Subsidiaries, the Administrator shall be the sole judge for purposes of this Plan (unless a contract or the award otherwise provides) of whether the participant continues to render services to the Corporation or one of its Subsidiaries and the date, if any, upon which such services shall be deemed to have terminated.

		
	6.2
	Events Not Deemed Terminations of Service.  Unless the express policy of the Corporation or one of its Subsidiaries, or the Administrator, otherwise provides, the employment relationship shall not be considered terminated in the case of (a) sick leave, (b) military leave, or (c) any other leave of absence authorized by the Corporation or one of its Subsidiaries, or the Administrator; provided that, unless reemployment upon the expiration of such leave is guaranteed by contract or law or the Administrator otherwise provides, such leave is for a period of not more than three months.  In the case of any employee of the Corporation or one of its Subsidiaries on an approved leave of absence, continued vesting of the award while on leave from the employ of the Corporation or one of its Subsidiaries may be suspended until the employee returns to service, unless the Administrator otherwise provides or applicable law otherwise requires.  In no event shall an award be exercised after the expiration of the term set forth in the applicable award agreement.

		
	6.3
	Effect of Change of Subsidiary Status.  For purposes of this Plan and any award, if an entity ceases to be a Subsidiary of the Corporation a termination of employment or service shall be deemed to have occurred with respect to each Eligible Person in respect of such Subsidiary who does not continue as an Eligible Person in respect of the Corporation or another Subsidiary that continues as such after giving effect to the transaction or other event giving rise to the change in status.

7.      ADJUSTMENTS; ACCELERATION
		
	7.1
	Adjustments.  Subject to Section 7.2, upon (or, as may be necessary to effect the adjustment, immediately prior to): any reclassification, recapitalization, stock split (including a stock split in the form of a stock dividend) or reverse stock split; any merger, combination, consolidation, or other reorganization; any spin-off, split-up, or similar extraordinary dividend distribution in respect of the Common Stock; or any exchange of Common Stock or other securities of the Corporation, or any similar, unusual or extraordinary corporate transaction in respect of the Common Stock; then the Administrator shall equitably and proportionately adjust (1) the number and type of shares of Common Stock (or other securities) that thereafter may be made the subject of awards (including the specific share limits, maximums and numbers of shares set forth elsewhere in this Plan), (2) the number, amount and type of shares of Common Stock (or other securities or property) subject to any outstanding awards, (3) the grant, purchase, or exercise price (which term includes the base price of any SAR or similar right) of any outstanding awards, and/or (4) the securities, cash or other property deliverable upon exercise or payment of any outstanding awards, in each case to the extent necessary to preserve (but not increase) the level of incentives intended by this Plan and the then-outstanding awards.

Unless otherwise expressly provided in the applicable award agreement, upon (or, as may be necessary to effect the adjustment, immediately prior to) any event or transaction described in the preceding paragraph or a sale of all or substantially all of the business or assets of the Corporation as an entirety, the Administrator 

9

 

shall equitably and proportionately adjust the performance standards applicable to any then-outstanding performance-based awards to the extent necessary to preserve (but not increase) the level of incentives intended by this Plan and the then-outstanding performance-based awards.
It is intended that, if possible, any adjustments contemplated by the preceding two paragraphs be made in a manner that satisfies applicable U.S. legal, tax (including, without limitation and as applicable in the circumstances, Section 424 of the Code, Section 409A of the Code and Section 162(m) of the Code) and accounting (so as to not trigger any charge to earnings with respect to such adjustment) requirements.
Without limiting the generality of Section 3.3, any good faith determination by the Administrator as to whether an adjustment is required in the circumstances pursuant to this Section 7.1, and the extent and nature of any such adjustment, shall be conclusive and binding on all persons.
		
	7.2
	Corporate Transactions - Assumption and Termination of Awards.  Upon the occurrence of any of the following: any merger, combination, consolidation, or other reorganization in connection with which the Corporation does not survive (or does not survive as a public company in respect of its Common Stock); any exchange of Common Stock or other securities of the Corporation in connection with which the Corporation does not survive (or does not survive as a public company in respect of its Common Stock); a sale of all or substantially all the business, stock or assets of the Corporation in connection with which the Corporation does not survive (or does not survive as a public company in respect of its Common Stock); a dissolution of the Corporation; or any other event in which the Corporation does not survive (or does not survive as a public company in respect of its Common Stock); then the Administrator may make provision for a cash payment in settlement of, or for the assumption, substitution or exchange of any or all outstanding share-based awards or the cash, securities or property deliverable to the holder of any or all outstanding share-based awards, based upon, to the extent relevant under the circumstances, the distribution or consideration payable to holders of the Common Stock upon or in respect of such event.  Upon the occurrence of any event described in the preceding sentence, then, unless the Administrator has made a provision for the substitution, assumption, exchange or other continuation or settlement of the award or the award would otherwise continue in accordance with its terms in the circumstances: (1) unless otherwise provided in the applicable award agreement, each then-outstanding option and SAR shall become fully vested, all shares of restricted stock then outstanding shall fully vest free of restrictions, and each other award granted under this Plan that is then outstanding shall become payable to the holder of such award; and (2) each award shall terminate upon the related event; provided that the holder of an option or SAR shall be given reasonable advance notice of the impending termination and a reasonable opportunity to exercise his or her outstanding vested options and SARs (after giving effect to any accelerated vesting required in the circumstances) in accordance with their terms before the termination of such awards (except that in no case shall more than ten days’ notice of the impending termination be required and any acceleration of vesting and any exercise of any portion of an award that is so accelerated may be made contingent upon the actual occurrence of the event).

Without limiting the preceding paragraph, in connection with any event referred to in the preceding paragraph or any change in control event defined in any applicable award agreement, the Administrator may, in its discretion, provide for the accelerated vesting of any award or awards as and to the extent determined by the Administrator in the circumstances.
The Administrator may adopt such valuation methodologies for outstanding awards as it deems reasonable in the event of a cash or property settlement and, in the case of options, SARs or similar rights, but without limitation on other methodologies, may base such settlement solely upon the excess if any of the per share amount payable upon or in respect of such event over the exercise or base price of the award.
In any of the events referred to in this Section 7.2, the Administrator may take such action contemplated by this Section 7.2 prior to such event (as opposed to on the occurrence of such event) to the extent that the Administrator deems the action necessary to permit the participant to realize the benefits intended to be conveyed with respect to the underlying shares.  Without limiting the generality of the foregoing, the Administrator may deem an acceleration to occur immediately prior to the applicable event and/or reinstate the original terms of the award if an event giving rise to an acceleration does not occur.
Without limiting the generality of Section 3.3, any good faith determination by the Administrator pursuant to its authority under this Section 7.2 shall be conclusive and binding on all persons.

10

 

		
	7.3
	Other Acceleration Rules.  The Administrator may override the provisions of Section 7.2 by express provision in the award agreement and may accord any Eligible Person a right to refuse any acceleration, whether pursuant to the award agreement or otherwise, in such circumstances as the Administrator may approve.  The portion of any ISO accelerated in connection with an event referred to in Section 7.2 (or such other circumstances as may trigger accelerated vesting of the award) shall remain exercisable as an ISO only to the extent the applicable $100,000 limitation on ISOs is not exceeded.  To the extent exceeded, the accelerated portion of the option shall be exercisable as a nonqualified stock option under the Code.

8.      OTHER PROVISIONS
		
	8.1
	Compliance with Laws.  This Plan, the granting and vesting of awards under this Plan, the offer, issuance and delivery of shares of Common Stock, and/or the payment of money under this Plan or under awards are subject to compliance with all applicable federal and state laws, rules and regulations (including but not limited to state and federal securities law and federal margin requirements) and to such approvals by any listing, regulatory or governmental authority as may, in the opinion of counsel for the Corporation, be necessary or advisable in connection therewith.  The person acquiring any securities under this Plan will, if requested by the Corporation or one of its Subsidiaries, provide such assurances and representations to the Corporation or one of its Subsidiaries as the Administrator may deem necessary or desirable to assure compliance with all applicable legal and accounting requirements.

		
	8.2
	No Rights to Award.  No person shall have any claim or rights to be granted an award (or additional awards, as the case may be) under this Plan, subject to any express contractual rights (set forth in a document other than this Plan) to the contrary.

		
	8.3
	No Employment/Service Contract.  Nothing contained in this Plan (or in any other documents under this Plan or in any award) shall confer upon any Eligible Person or other participant any right to continue in the employ or other service of the Corporation or one of its Subsidiaries, constitute any contract or agreement of employment or other service or affect an employee’s status as an employee at will, nor shall interfere in any way with the right of the Corporation or one of its Subsidiaries to change a person’s compensation or other benefits, or to terminate his or her employment or other service, with or without cause.  Nothing in this Section 8.3, however, is intended to adversely affect any express independent right of such person under a separate employment or service contract other than an award agreement.

		
	8.4
	Plan Not Funded.  Awards payable under this Plan shall be payable in shares or from the general assets of the Corporation, and no special or separate reserve, fund or deposit shall be made to assure payment of such awards.  No participant, beneficiary or other person shall have any right, title or interest in any fund or in any specific asset (including shares of Common Stock, except as expressly otherwise provided) of the Corporation or one of its Subsidiaries by reason of any award hereunder.  Neither the provisions of this Plan (or of any related documents), nor the creation or adoption of this Plan, nor any action taken pursuant to the provisions of this Plan shall create, or be construed to create, a trust of any kind or a fiduciary relationship between the Corporation or one of its Subsidiaries and any participant, beneficiary or other person.  To the extent that a participant, beneficiary or other person acquires a right to receive payment pursuant to any award hereunder, such right shall be no greater than the right of any unsecured general creditor of the Corporation.

		
	8.5
	Tax Withholding.  Upon any exercise, vesting, or payment of any award or upon the disposition of shares of Common Stock acquired pursuant to the exercise of an ISO prior to satisfaction of the holding period requirements of Section 422 of the Code, or upon any other tax withholding event with respect to any award, the Corporation or one of its Subsidiaries shall have the right at its option to:

		
	(a)
	require the participant (or the participant’s personal representative or beneficiary, as the case may be) to pay or provide for payment of at least the minimum amount of any taxes which the Corporation or one of its Subsidiaries may be required to withhold with respect to such award event or payment; or

		
	(b)
	deduct from any amount otherwise payable in cash to the participant (or the participant’s personal representative or beneficiary, as the case may be) the minimum amount of any taxes which the Corporation or one of its Subsidiaries may be required to withhold with respect to such cash payment.

11

 

In any case where a tax is required to be withheld in connection with the delivery of shares of Common Stock under this Plan, the Administrator may in its sole discretion (subject to Section 8.1) require or grant (either at the time of the award or thereafter) to the participant the right to elect, pursuant to such rules and subject to such conditions as the Administrator may establish, that the Corporation reduce the number of shares to be delivered by (or otherwise reacquire) the appropriate number of shares, valued in a consistent manner at their fair market value or at the sales price in accordance with authorized procedures for cashless exercises, necessary to satisfy the minimum applicable withholding obligation on exercise, vesting or payment.  In no event shall the shares withheld exceed the minimum whole number of shares required for tax withholding under applicable law.

		
	8.6
	Effective Date, Termination and Suspension, Amendments.

		
	8.6.1
	Effective Date.  This version of the Plan is effective as of April 2, 2014, the date of its approval by the Board (the “Effective Date”).  This Plan shall be submitted for and subject to stockholder approval no later than twelve months after the Effective Date.  Unless earlier terminated by the Board, this Plan shall terminate at the close of business on the day before the tenth anniversary of the Effective Date.  After the termination of this Plan either upon such stated expiration date or its earlier termination by the Board, no additional awards may be granted under this Plan, but previously granted awards (and the authority of the Administrator with respect thereto, including the authority to amend such awards) shall remain outstanding in accordance with their applicable terms and conditions and the terms and conditions of this Plan.

		
	8.6.2
	Board Authorization.  The Board may, at any time, terminate or, from time to time, amend, modify or suspend this Plan, in whole or in part.  No awards may be granted during any period that the Board suspends this Plan.

		
	8.6.3
	Stockholder Approval.  To the extent then required by applicable law or any applicable listing agency or required under Sections 162, 422 or 424 of the Code to preserve the intended tax consequences of this Plan, or deemed necessary or advisable by the Board, any amendment to this Plan shall be subject to stockholder approval.  In addition, the no repricing provision included in Section 3.2 may not be amended without shareholder approval.

		
	8.6.4
	Amendments to Awards.  Without limiting any other express authority of the Administrator under (but subject to) the express limits of this Plan, the Administrator by agreement or resolution may waive conditions of or limitations on awards to participants that the Administrator in the prior exercise of its discretion has imposed, without the consent of a participant, and (subject to the requirements of Sections 3.2 and 8.6.5) may make other changes to the terms and conditions of awards.  Any amendment or other action that would constitute a repricing of an award is subject to the limitations set forth in Section 3.2(g).

		
	8.6.5
	Limitations on Amendments to Plan and Awards.  No amendment, suspension or termination of this Plan or amendment of any outstanding award agreement shall, without written consent of the participant, affect in any manner materially adverse to the participant any rights or benefits of the participant or obligations of the Corporation under any award granted under this Plan prior to the effective date of such change.  Changes, settlements and other actions contemplated by Section 7 shall not be deemed to constitute changes or amendments for purposes of this Section 8.6.

		
	8.7
	Privileges of Stock Ownership.  Except as otherwise expressly authorized by the Administrator, a participant shall not be entitled to any privilege of stock ownership as to any shares of Common Stock not actually delivered to and held of record by the participant.  Except as expressly required by Section 7.1 or otherwise expressly provided by the Administrator, no adjustment will be made for dividends or other rights as a stockholder for which a record date is prior to such date of delivery.

		
	8.8
	Governing Law; Construction; Severability.

		
	8.8.1
	Choice of Law.  This Plan, the awards, all documents evidencing awards and all other related documents shall be governed by, and construed in accordance with the laws of the State of Maryland.

12

 

		
	8.8.2
	Severability.  If a court of competent jurisdiction holds any provision invalid and unenforceable, the remaining provisions of this Plan shall continue in effect.

		
	8.8.3
	Plan Construction.

		
	(a)
	Rule 16b-3.  It is the intent of the Corporation that the awards and transactions permitted by awards be interpreted in a manner that, in the case of participants who are or may be subject to Section 16 of the Exchange Act, qualify, to the maximum extent compatible with the express terms of the award, for exemption from matching liability under Rule 16b-3 promulgated under the Exchange Act.  Notwithstanding the foregoing, the Corporation shall have no liability to any participant for Section 16 consequences of awards or events under awards if an award or event does not so qualify.

		
	(b)
	Section 162(m).  Awards under Section 5.1.4 to persons described in Section 5.2 that are either granted or become vested, exercisable or payable based on attainment of one or more performance goals related to the Business Criteria, as well as Qualifying Options and Qualifying SARs granted to persons described in Section 5.2, that are approved by a committee composed solely of two or more outside directors (as this requirement is applied under Section 162(m) of the Code) shall be deemed to be intended as performance-based compensation within the meaning of Section 162(m) of the Code unless such committee provides otherwise at the time of grant of the award.  It is the further intent of the Corporation that (to the extent the Corporation or one of its Subsidiaries or awards under this Plan may be or become subject to limitations on deductibility under Section 162(m) of the Code) any such awards and any other Performance-Based Awards under Section 5.2 that are granted to or held by a person subject to Section 162(m) will qualify as performance-based compensation or otherwise be exempt from deductibility limitations under Section 162(m).

		
	8.9
	Captions.  Captions and headings are given to the sections and subsections of this Plan solely as a convenience to facilitate reference.  Such headings shall not be deemed in any way material or relevant to the construction or interpretation of this Plan or any provision thereof.

		
	8.10
	Stock-Based Awards in Substitution for Stock Options or Awards Granted by Other Corporation.  Awards may be granted to Eligible Persons in substitution for or in connection with an assumption of employee stock options, SARs, restricted stock or other stock-based awards granted by other entities to persons who are or who will become Eligible Persons in respect of the Corporation or one of its Subsidiaries, in connection with a distribution, merger or other reorganization by or with the granting entity or an affiliated entity, or the acquisition by the Corporation or one of its Subsidiaries, directly or indirectly, of all or a substantial part of the stock or assets of the employing entity.  The awards so granted need not comply with other specific terms of this Plan, provided the awards reflect only adjustments giving effect to the assumption or substitution consistent with the conversion applicable to the Common Stock in the transaction and any change in the issuer of the security.  Any shares that are delivered and any awards that are granted by, or become obligations of, the Corporation, as a result of the assumption by the Corporation of, or in substitution for, outstanding awards previously granted by an acquired company (or previously granted by a predecessor employer (or direct or indirect parent thereof) in the case of persons that become employed by the Corporation or one of its Subsidiaries in connection with a business or asset acquisition or similar transaction) shall not be counted against the Share Limit or other limits on the number of shares available for issuance under this Plan.

		
	8.11
	Non-Exclusivity of Plan.  Nothing in this Plan shall limit or be deemed to limit the authority of the Board or the Administrator to grant awards or authorize any other compensation, with or without reference to the Common Stock, under any other plan or authority.

		
	8.12
	No Corporate Action Restriction.  The existence of this Plan, the award agreements and the awards granted hereunder shall not limit, affect or restrict in any way the right or power of the Board or the stockholders of the Corporation to make or authorize: (a) any adjustment, recapitalization, reorganization or other change in the capital structure or business of the Corporation or any Subsidiary, (b) any merger, amalgamation, consolidation or change in the ownership of the Corporation or any Subsidiary, (c) any issue of bonds, debentures, capital, preferred or prior preference stock ahead of or affecting the capital stock (or the rights thereof) of the Corporation or any Subsidiary, (d) any dissolution or liquidation of the Corporation or any Subsidiary, (e) any sale or transfer of all or any part of the assets or business of the Corporation or any 

13

 

Subsidiary, or (f) any other corporate act or proceeding by the Corporation or any Subsidiary.  No participant, beneficiary or any other person shall have any claim under any award or award agreement against any member of the Board or the Administrator, or the Corporation or any employees, officers or agents of the Corporation or any Subsidiary, as a result of any such action.
		
	8.13
	Other Company Benefit and Compensation Programs.  Payments and other benefits received by a participant under an award made pursuant to this Plan shall not be deemed a part of a participant’s compensation for purposes of the determination of benefits under any other employee welfare or benefit plans or arrangements, if any, provided by the Corporation or any Subsidiary, except where the Administrator expressly otherwise provides or authorizes in writing.  Awards under this Plan may be made in addition to, in combination with, as alternatives to or in payment of grants, awards or commitments under any other plans or arrangements of the Corporation or its Subsidiaries.

9.      DEFINITIONS
Unless otherwise expressly provided in the applicable award agreement, the following terms shall have the meanings set forth in this Section 9 for purposes of awards granted hereunder to the extent any such terms are used with respect to such an award:
A “Change in Control” of the Corporation shall be deemed to have occurred if any of the following events occurs:
		
	(i)
	Any “person” or “group” (within the meaning of Sections 13(d) and 14(d)(2) of the Exchange Act), other than a trustee or other fiduciary holding securities under an employee benefit plan of the Corporation (an “Acquiring Person”), is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of more than 33 1/3% of the then outstanding voting stock of the Corporation;

		
	(ii)
	A merger or consolidation of the Corporation with any other corporation, other than a merger or consolidation which would result in the voting securities of the Corporation outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least 51% of the combined voting power of the voting securities of the Corporation or surviving entity outstanding immediately after such merger or consolidation;

		
	(iii)
	A sale or other disposition by the Corporation of all or substantially all of the Corporation’s assets;

		
	(iv)
	During any period of two (2) consecutive years (beginning on or after the Effective Date), individuals who at the beginning of such period constitute the Board and any new director (other than a director who is a representative or nominee of an Acquiring Person) whose election by the Board or nomination for election by the Corporation’s shareholders was approved by a vote of at least a majority of the directors then still in office who either were directors at the beginning of the period or whose election or nomination was previously so approved, no longer constitute a majority of the Board;

provided, however, in no event shall any acquisition of securities, a change in the composition of the Board or a merger or other consolidation pursuant to a plan of reorganization under chapter 11 of the Bankruptcy Code with respect to the Corporation (“Chapter 11 Plan”), or a liquidation under the Bankruptcy Code constitute a Change in Control.  In addition, notwithstanding Sections 12(d)(i), 12(d)(ii), 12(d)(iii) and 12(d)(iv) hereof, a Change in Control shall not be deemed to have occurred in the event of a sale or conveyance in which the Corporation continues as a holding company of an entity or entities that conduct the business or businesses formerly conducted by the Corporation, or any transaction undertaken for the purpose of reincorporating the Corporation under the laws of another jurisdiction, if such transaction does not materially affect the beneficial ownership of the Corporation’s capital stock.
“Disability” with respect to a participant means that the participant has experienced one of the following: (1) the participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, or (2) the participant is, by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than three months under an accident and health plan covering employees of the participant’s employer.

14

 

“Good Cause” with respect to a participant means (unless otherwise expressly provided in the applicable agreement setting forth the terms and conditions of the award, or another applicable contract with the participant that defines such term for purposes of determining the effect that a “for cause” termination has on the participant’s awards) any one of the following: (A) any criminal conviction of the participant under the laws of the United States or any state or other political subdivision thereof which, in the good faith determination of the Corporation renders the participant unsuitable as an employee or officer of the Corporation or any Subsidiary; (B) the participant’s continued failure to substantially perform the duties reasonably requested by the Corporation and commensurate with the participant’s position and within the participant’s control in such position (other than any such failure resulting from participant’s incapacity due to the participant’s Disability) after a written demand for substantial performance is delivered to the participant by the Corporation, which demand specifically identifies the manner in which the Corporation believes that the participant has not substantially performed the participant’s duties, and which performance is not substantially corrected by the participant within ten (10) days of receipt of such demand; or (C) any material workplace misconduct or willful failure to comply with the Corporation’s general policies and procedures as they may exist from time to time by the Corporation which, in the good faith determination of the Corporation, renders the participant unsuitable as an employee or officer of Corporation.
“Good Reason” with respect to a participant means (unless otherwise expressly provided in the applicable agreement setting forth the terms and conditions of the award, or another applicable contract with the participant that defines such term for purposes of determining the effect that a “good reason” termination has on the participant’s awards) a resignation of the participant’s employment with the Corporation as a result of and within 60 days after the occurrence of any of the following without the participant’s written consent:  (A) a meaningful and detrimental reduction in the participant’s authority, duties or responsibilities, or a meaningful and detrimental change in the participant’s reporting responsibilities, as in effect immediately prior to the participant’s termination of employment; (B) a material reduction in the participant’s annual base salary as in effect immediately prior to the participant’s delivery of notice to the Corporation stating the basis of the participant’s allegation that “Good Reason” exists (the “Good Reason Notice”), a material reduction in the participant’s target annual bonus (expressed as a percentage of base salary), if any, as in effect immediately prior to the circumstances described in the Good Reason Notice, or a material failure to provide the participant with any other form of compensation or material employment benefit being provided to the participant immediately prior to the circumstances described in the Good Reason Notice (excluding however, any reduction in the amount of any annual bonus or the granting or withholding of incentive compensation (including without limitation options or restricted stock units) but including a material reduction to the target amount of the bonus as stated above); or (C) a relocation of the participant’s principal place of employment by more than fifty (50) miles (or the requirement that the participant be based at a different location), provided that such relocation results in a longer commute (measured by actual mileage) for the participant from his or her primary residence to such new location.  Notwithstanding the foregoing, for any of the foregoing circumstances to constitute “Good Reason” hereunder, (x) the participant must deliver the Good Reason Notice to the Corporation within 30 days of the date on which the circumstances creating “Good Reason” have first occurred, (y) such circumstances are not corrected by the Corporation in a manner that is reasonably satisfactory to the participant (including full retroactive correction with respect to any monetary matter) within 30 days of the Corporation’s receipt of the Good Reason Notice from the participant and, (z) the participant thereafter resigns his or her employment within the 60 day time period described above.
A “Separation from Service” shall mean a “separation from service” within the meaning of Treasury Regulation Section 1.409A-1(h)(1), without regard to the optional alternative definitions available thereunder.
An “Unforeseeable Emergency” means a severe financial hardship to the participant resulting from (i) an illness or accident of the participant, the participant’s spouse, or a dependent (as defined in Section 152(a) of the Code without regard to paragraphs (b)(1), (b)(2) and (d)(1)(b) thereof) of the participant, (ii) loss of the participant’s property due to casualty, or (iii) other similar extraordinary and unforeseeable circumstances arising as a result of events beyond the control of the participant, all as determined by the Administrator in its sole discretion and in all events constituting an “unforeseeable emergency” within the meaning of Section 409A of the Code.

15EWELLNESS
CORPORATION AND MILLENNIUM HEALTHCARE, INC. 

 

SUPPLY
AND DISTRIBUTION AGREEMENT

 

This Agreement
(this “Agreement”) is made and entered into effective as of May 24, 2013 (the “Effective Date”) by and
between:

 

A.
eWellness Corporation (“EWC” and or “EWC”), a EWC organized under the laws of Nevada
, principal place of business at 2360 Corporate Circle, Suite 400, Henderson Nevada 89074-7722 and

 

B. Millennium
Healthcare, Inc., (“MHI”), a Delaware corporation having an address at 400 Garden City Plaza, Suite 440, Garden
City, New York 11530.

 

Each may
be referred to herein as a “Party” or, collectively, the “Parties.”

 

ARTICLE
1

 

DEFINITIONS

 

“Effective
Date” shall have the meaning set forth in  the introductory paragraph of this Agreement.

 

“EWC
Products” are those Distance Monitoring Physical Therapy (“DMpt”) Programs that are listed in and are attached
hereto as Exhibit A, as may be amended from time to time, and all improvements thereto. EWC is under no obligation to include
new technologies or platforms developed after the effective date of this agreement.

 

“EWC
Products Territory” shall mean the 14 states that include: Maine, New Hampshire, Massachusetts, Rhode Island, Connecticut,
New York, New Jersey, Delaware Maryland, Virginia, North Carolina, Georgia and Florida.

 

MHI may
request that the EWC DMpt program can be offered by MHI in other states at the discretion of both EWC and MHI.

 

“EWC
Shares” shall mean the shares of EWC’s restricted common stock referred to in Section 2.4 of this
Agreement.

 

ARTICLE
2

 

SUPPLY
AND DISTRIBUTION AGREEMENT

 

Supply
and Distribution Agreement. EWC hereby enters into a Supply and Distribution agreement with MHI for EWC’s Product(s)
for use as described in Exhibit A in the assigned EWC Products Territory. Subject to the terms and conditions set forth herein,
EWC grants to MHI, and MHI hereby accepts, a limited, transferable right to use its best efforts as one of EWC’s partners
to promote and use the EWC’s DMpt programs.

 

    	 

    	 

    

 

2.1 Use
of Trademarks.

 

2.1.1 Ownership.
MHI recognizes the validity of EWC’s trademarks and trade name (collectively “Trademarks”), acknowledges that
the same are the property of EWC, and agrees that MHI owns no interest in, and agrees not to infringe upon, harm or contest the
rights of EWC to its Trademarks. MHI will not take any action in derogation of EWC’s rights to its Trademarks.

 

2.1.2 Use
of Trademarks and Trade Names. So long as this Agreement is in effect, MHI shall have the right to use EWC’s Trademarks
or trade names solely in connection with its activities hereunder. MHI’s use shall be limited to EWC Products and marketing
material provided by EWC and pre-approved sales and marketing material produced by MHI. MHI shall not use any of EWC’s Trademarks,
except in connection with its distribution of EWC Products under the terms of this Agreement.

 

2.1.3 Termination.
MHI agrees that upon termination of this Agreement for any reason it will discontinue the use of and destroy or return as directed
by EWC, any samples and materials as well as advertising, or other materials bearing any of EWC’s Trademarks.

 

2.1.4 Packaging.
Any packaging shall comply with the rules and regulations of any regulatory body having jurisdiction over such packaging.

 

2.2 Back
End Customer Support. EWC shall provide the following support to MHI: EWC representatives will be available to provide
support to MHI technical service representatives within 12 to 48 hours.

 

2.3 Equity
Earn In.

 

2.3.1 The
EWC hereby agrees that for every $100,000.00 of in revenue from MHI’s for the services provided hereunder for EWC’s
DMpt program, it will issue 110,000 shares of EWC Shares to MHI, up to a maximum amount of 1.1 million EWC Shares, which amount
represents a total of ten (10%) of the current anticipated issued and outstanding (11 million shares of common stock) common stock
of the EWC at the date of this Agreement. This number will be adjusted in the case of a reverse splits, so that the current value
received is continued under a lower number of shares outstanding.

 

2.3.2 MHI
agrees that it is acquiring the EWC Shares for its own account for investment purposes only and not with an intention to resell
or distribute such shares.

 

2.3.3 MHI
agrees that the EWC Shares are restricted securities as defined in Rule 144(a)(3) promulgated under the Securities Act of 1933,
as amended (the “Act”), and, as such, may not be resold or transferred except pursuant to an effective registration
statement filed under the Act or an exemption from the registration requirements of the Act. EWC shall have the right to request
an opinion letter reasonably acceptable to its counsel in the case of a sale or transfer not made pursuant to an effective registration
statement.

 

    	2

    	 

    

  

ARTICLE
3

 

PRODUCT
SUPPLY AND MINIMUM PURCHASE REQUIREMENTS

 

3.1 Agreement
to Supply and Pricing. EWC agrees to provide the EWC DMpt program identified in Exhibit A hereto attached to MHI for Distance
Monitored Physical Therapy services within terms of this Agreement. EWC agrees to pay the MHI for promoting EWC’s PT Evaluations,
Re evaluations and Physical tests and any other services provided by EWC and or its personnel that would be performed by EWC staff
and or EWC online distance monitored offerings. These services will be bill for insurance reimbursement by EWC for all evaluations
testing and the 24-week On-line Exercise Programs. MHI will charge EWC a fixed billing fee for any services provided.

 

3.2 Quality
Control. The EWC shall at all times provide their DMpt program in conformity with good practices of the physical therapy
industry in the United States, which shall be no lower than such standards as are customary for the EWC’s other customers
obtaining comparable products or services.

 

3.3 Compliance.
The DMpt program provided hereunder shall conform to and be in compliance with all applicable laws and regulations, be free
from defect, claim, encumbrance or lien, and fit for the particular purpose and use intended by EWC patients. The EWC represents
and expressly warrants that it has and shall at all times throughout the term of this Agreement has, whether by right, title or
interest, including by license or otherwise, the intellectual property rights that are required to use, manufacture, market ,
offer to sell, sell, import and export the DMpt program in accordance with the terms of this Agreement and that neither this Agreement
nor the act of any party pursuant hereto shall infringe any third party rights. The EWC further warrants that it shall comply
with all applicable laws and regulations with respect to the provisioning of the MDpt program to MHI, and any Product sold and
delivered by the EWC to MHI will be suitable for sale to its customers and that the DMpt program provided hereunder may be lawfully
sold to the end users in the United States of America.

 

3.4 Conditions
of Sale. These terms and conditions govern all sales and shipments by EWC and EWC hereby gives notice of refusal to honor
any different or additional terms and conditions, except for such as may be expressly accepted by EWC in writing.

 

3.4.1 Limited
Warranty. EWC warrants that the MDpt program is sold by it will be free of defects in workmanship or material for one (1)
year as of the date of shipment to MHI. Should the EWC Products upon delivery fail to conform to this warranty, EWC shall, upon
prompt written notice from MHI, correct such non-conformity either by replacement or by refund of the purchase price, at EWC’s
option in its sole discretion. Return of EWC Products to EWC pursuant to this paragraph shall be at EWC’s risk and expense.
THE FOREGOING WARRANTY IS IN LIEU OF ALL OTHER WARRANTIES OF QUALITY WHETHER WRITTEN, ORAL, OR IMPLIED, INCLUDING ANY WARRANTY
OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.

 

The
foregoing limited warranty shall not apply to any EWC DMpt program product or part (a) which has been improperly altered, (b)
subjected to misuse, misapplication, negligence or accident, or (c) used in a manner contrary to EWC’s directions, or (d)
t provided or for which the design was stipulated by MHI.

 

3.4.2 Limitation
of liability. Whether on account of any alleged breach of this agreement or defects claimed for EWC products furnished hereunder,
delays in delivery or any other claim based upon or with respect to such EWC products, in no event shall EWC be liable to MHI
for special, indirect, incidental or consequential damages including, but not limited to, loss of profits or revenue, loss of
use of products or facilities or services, downtime cost, or claims of customers of the MHI for such other damages. EWC’s
liability on any claim whether in contract, tort (including  negligence) warranty, strict
liability, or otherwise for any loss or damage arising out of, connected with, or from the design, manufacture, sale, delivery,
resale. Repair, replacement , installation, or use of any product or part covered by or furnished under this contract shall in
no case exceed the purchase price allocable to the EWC Product or part thereof which gives rise to the claim. All causes of action
against EWC arising out of or relating to this contract or the performance hereof shall expire unless brought within one (1) year
of the time of accrual thereof.

 

    	3

    	 

    

  

ARTICLE
4

 

RENEW
AL PRICES AND PAYMENT

 

4.1 Payment
Terms. All DMpt program billing, based upon actual insurance reimbursements received by EWC from a patient and or
their insurance company, shall pay MHI for any of its associated billing fees for the services provided for within 5 business
days of receipt of such funds.

 

4.2 Taxes
and Duties. MHI agrees to pay, and to indemnify and hold EWC harmless from, any and all of the following : sales, use
or privilege taxes, excise or similar taxes, value added taxes, import and export taxes, duties, or assessments and any other
related charged levied by any jurisdiction pertaining to the EWC DMpt program services, other than taxes computed on the net income
of EWC. If EWC agrees to advance or pay any of such taxes or charges. MHI agrees to reimburse EWC for same within thirty (30)
days or presentation of billing statements for such taxes or charges.

 

5.1
Recalls or Corrective Actions. MHI shall fully cooperate with EWC in any decision by EWC with respect to EWC DMpt
program, to recall, retrieve and/or replace its program. All costs and expenses associated with such recalls and corrective
actions shall be borne solely by EWC.

 

5.2
No Alteration. Each party shall not remove, obliterate, or in any other manner affect, any trademark, trade name, certification
mark, testing seal, means of identification, instructional or safety warning, or other marking of the other, whether affixed to
the EWC DMpt program materials or otherwise. MHI shall not make any changes in the literature, warnings, labels or advertising
under which EWC prescribes that the EWC ’s DMpt program is to be sold without EWC’s prior written authorization, and
EWC shall deliver to MHI all such literature, warning, labels and materials to be provided by MHI to its customers.

 

ARTICLE
6

 

INDEMNIFICATIONS

 

6.1 Indemnification.

 

6.1.1
The EWC agrees to indemnify and hold MHI, its managers, members, officers, and employees (collectively, “MHI Indemnified
Parties”; each, a “MHI Indemnified Party”) harmless from and against any and all costs, losses, liabilities,
damages, claims or expenses (including without limitation reasonable attorney’s fees and expenses) (collectively, “Losses”)
incurred by an Indemnified Party arising out of, related to, occasioned by or attributable to: (i) any claims made against a MHI
Indemnified Party related to any of the Products sold, marketed or distributed by MHI; (ii) any breach by the EWC or any of its
directors, officers, employees or agents of any representation, warranty or covenant made by the EWC herein; or (iii) the gross
negligence or willful misconduct on the part of the EWC, or any of its directors, officers, employees or agent s in its/their
performance of this Agreement. Notwithstanding anything herein to the contrary, the foregoing indemnity will not apply to Losses
to the extent that such Losses have resulted from the willful misconduct, bad faith, fraud or gross negligence of or breach of
this Agreement by, a MHI Indemnified Party.

 

    	4

    	 

    

  

6.1.2
MHI shall indemnify and hold the EWC and its directors, officers, employees and shareholders (collectively, “EWC Indemnified
Parties”; each, a “EWC Indemnified Party”) harmless from any Losses incurred by a EWC Indemnified Party arising
out of, related to, occasioned by or attributable to: (i) any breach by MHI or any of its managers, members, officers or employees
of any representation, warranty or covenant made by MHI herein; or (ii) the gross negligence or willful misconduct on the part
of MHI, or any of its managers, members, officers or employees in its/their performance of this Agreement. Notwithstanding anything
herein to the contrary, the foregoing indemnity will not apply to Losses to the extent tha t such Losses have resulted from the
willful misconduct, bad faith, fraud or gross negligence of, or breach of this Agreement by, a EWC Indemnified Party.

 

ARTICLE
7

 

TERM
AND TERMINATION

 

7.1
Term. This Agreement shall become effective as of the
Effective Date, and unless earlier terminated in accordance with any provision hereof, shall remain in force and effect for a
period of 25 years (Twenty Five). Unless this Agreement has been terminated as provided herein, this Agreement will be renewed
annually thereafter unless otherwise terminated by the parties in accordance with its terms.

 

7.2
Other Rights of Termination. The EWC may terminate this
Agreement by giving written notice to MHI of such termination upon the occurrence of any of the following events:

 

7.2.1
any material breach of this Agreement by MHI or EWC;

 

7.2.2
dissolution of MHI or EWC for any reason;

 

7.2.3
if MHI shall be restrained, prevented or hindered for a continuous period of sixty (60) days from transacting a substantial part
of its business by reason of a judgment, decree, order, rule or regulation of any court, or of any administrative or governmental
authority or agency; or

 

7.2.4
if MHI and or the EWC shall become subject to any action or proceeding in the nature of a bankruptcy proceeding under United States
or other law or shall make an arrangement with its creditors, or shall make an assignment for the benefit of its creditors, or
a receiver, custodian, trustee, liquidator or comparable officer shall be appointed for MHI and or the EWC or its businesses.

 

7.2.5
MHI may terminate this Agreement at any time by giving 30-day written notice to the EWC. Such termination shall not relieve MHI
from the requirement to make the payments under Section 3.3 above.

 

7.3 Effect
of Termination. Upon any expiration or termination of this Agreement:

 

7.3.1 Neither
party shall thereby be discharged from any liability or obligation to the other party which became due or payable prior to the
effective date of such expiration or termination;

 

7.3.2
Those Sections of this Agreement which by their nature extend beyond termination, including but not limited to those in Articles
6 (“Indemnification”) and 9 (“General Provisions”) shall continue;

 

    	5

    	 

    

  

7.3.3
MHI’s appointment as an authorized regional lab partner of EWC as more fully set forth herein shall immediately terminate,
and MHI shall immediately cease any representations that it is an authorized regional lab partner ;

 

7.3.4
MHI will, upon request by EWC, transfer to EWC any product registrations, licenses or permits or other similar items which may
have been obtained in the name of MHI, or jointly in the name of EWC and MHI, pursuant to this Agreement; and

 

7.3.5
The payment date of all monies due to one party by the other party shall automatically be accelerated so that they shall become
due and payable on the effective date of expiration or termination.

 

ARTICLE
8

 

GENERAL
PROVISIONS

 

8.1
Assignment. This Agreement shall be binding upon and shall inure to the benefit of the parties and their permitted
successors and assigns, and shall be assignable by MHI to any of it’s affiliates or subsidiaries. This Agreement may be
assigned if, MHI is acquired by another entity.

 

8.2
Governing Law. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties
hereto shall be governed, construed and interpreted in accordance with the laws of the State of New York, without regard to its
conflicts of laws principles. Each party hereby irrevocably and unconditionally consents and agrees that all actions, suits or
other proceedings arising under or in connection with this Agreement shall be tried and litigated in state or federal courts located
in the county of Nassau in the State of New York, which courts shall have exclusive jurisdiction to hear and determine any and
all claims, controversies and disputes arising out of or related to this Agreement and each party hereto waives any objection
it may have now or hereafter have to venue or to convenience of forum.

 

8.3
Amendment. This Agreement may be amended or supplemented only by a writing that refers explicitly to this Agreement
and that is signed on behalf of both parties.

 

8.4
Waiver. No waiver will be implied from conduct or failure to enforce rights. No waiver will be effective unless in
writing signed on behalf of the party against whom the waiver is asserted.

 

8.5
Force Majeure. Neither party will have the right to claim damages or to terminate this Agreement as a result of the
other party’s failure or delay in performance due to circumstances beyond its reasonable control (except for obligations
relating to fees payable under this Agreement) including, but not limited to, labor disputes, strikes, lockouts, shortages of
or inability to manufacture or obtain the EWC Products hereunder, labor, energy, components , raw materials or supplies, war,
riot, insurrection, epidemic, acts of God, or governmental action not the fault of the nonperforming party.

 

8.6 Severability.
If any provision of this Agreement is held unenforceable or invalid by a court of competent jurisdiction, such unenforceability
or invalidity shall not render this Agreement unenforceable or invalid as a whole. Rather, such provision shall be stricken from
this Agreement and the remaining provisions shall be fully enforceable.

 

8.7 Counterparts.
This Agreement may be executed in any number of counterparts and by the parties hereto in separate counterparts, each of which
when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same Agreement.
Any executed signature page delivered by facsimile transmission shall be binding to the same extent as an original executed signature
page, without regard to any agreement subject to the terms hereof or any amendment thereto.

 

    	6

    	 

    

 

8.8 Notices.
All notices shall be in writing and shall be by personal delivery, or by certified or registered mail, return receipt requested,
and deemed given upon personal delivery, or five (5) days after deposit in the mail. Notices shall be sent to the addresses set
forth below or such other address as either party may specify in writing:

 

MHI:

 

Chris Amandola,
President

Millennium
Healthcare, Inc.

400 Garden
City Plaza, Suite 440

Garden City,
New York 11530

 

EWC:

 

Darwin Fogt,

MPT President
& CEO

EWellness
Corporation

2360 Corporate
Circle, Suite 400

Henerson,
Nevada 89074-7722

 

With a copies
to:

 

Hunter Taubman
Weiss

17 State
Street, Floor 20

New York,
NY 10004

P: 917-512-0848

F: 212-202-6380

Attention:
Louis E. Taubman, Esq.

E-Mail:
ltaubman@,htwlaw.com

 

Abrams,
Fensterman, Fensterman, Eisman, Formato,

Ferrara
& Einiger, LLP

1111 Marcus
Ave., Suite 107

Lake Success,
NY 11042

Attention:
Ayman Soliman, Esq.

Tel: (516)
328-2300

Fax: (516)
328-6638

Email: asoliman@abramslaw.com

 

8.9
Relationship of Parties; Use of Names. The parties to
this Agreement are independent contractors. Neither party has authority to bind the other or to incur any obligation on the other
party’s behalf. Neither party will use the name of the other party except as necessary to comply with any applicable regulations.

 

    	7

    	 

    

 

8.10
Confidentiality. The parties to this Agreement respect
the confidentiality of its contractual relationships. Each party agrees to not disclose any confidential information received
from the other party in connection with this Agreement to any third party unless (i) such disclosure is approved in writing by
the non-disclosing party or (ii) such disclosure is required by law or governmental regulation and the party requested to disclose
such information has notified the other party in advance in writing. Neither party shall have any obligation with respect to the
confidential information of the other party if (i) at the time of receipt, such information is in the public domain or subsequently
enters the public domain without fault of the receiving party, (ii) at the time of receipt, the information was already known
to the receiving party as evidenced by appropriate written records, (iii) such information becomes available to the receiving
party from a bona-fide third-party source other than the disclosing party provided that such third-party source is not bound to
any confidentiality obligations to the disclosing party; and (iv) such information is independently developed by the receiving
party, as documented by appropriate written records. Upon termination or expiration of this Agreement, the receiving party shall
cease all use of the other party’s confidential information and, if requested, return all confidential information received.
The obligations set forth in this Section 9.9 shall continue beyond the termination or expiration of this Agreement, and for so
long as either party possesses confidential information of the other party.

 

8.11
Arbitration. Any disputes arising under this Agreement will be submitted to binding arbitration through the American
Arbitration Association. Each party shall select one arbitrator and the two arbitrators so selected shall select a third arbitrator
so that the three arbitrators shall govern the arbitration process and issue decisions that shall be binding upon the parties.
Any such arbitration shall take place at a location agreed to by both parties at the time of arbitration.

 

8.12
Legal Fees. In the event of any legal action, arbitration or other proceeding arising out of this Agreement, the prevailing
party shall be entitled to recover reasonable attorneys’ fees and other costs incurred therein, in addition to any other
relief to which it may be entitled.

 

8.13
Entire Agreement. This Agreement, including all exhibits to this Agreement, which are hereby incorporated by reference,
represents the entire agreement between the parties relating to its subject matter and supersedes all prior representations, discussions,
negotiations and agreements, whether written or oral.

 

8.14
Authority to Execute; Counterparts. Each of the undersigned represents and warrants that he/she has the right, legal
capacity and authority to enter into this Agreement and that the execution of this Agreement has been authorized by the party
on whose behalf the undersigned is executing this Agreement. This Agreement may be signed in counterparts which taken together
shall constitute one document.

 

	Millennium
    Healthcare Solutions, Inc.	 	eWellness
    Corporation
	 	 	 
	By:	/s/
    Chris Amandola	 	By:	/s/
    Douglas MacLellan
	 	Chris
    Amandola, President	 	 	Douglas
    MacLellan, Chairman & Secretary

  

    	8

    	 

    

 

EXHIBIT
A

 

THE
DMpt Program

 

CREATING
A PARTNERSIDP TO PROVIDE DISTANCE MONITORED PHYSICAL THERAPY

 

eWellness
Corporation is a privately held Nevada corporation that provides Distance Monitored Physical Therapy Programs to diabetic and
health challenged patients, through contracted physician practices and healthcare systems. EWC’s plan is to become the new
“Go-To” physical therapy solution in the national diabetes and obesity epidemic.

 

eWELLNESS
DISTANCE MONITORED PHYSICAL THERAPY PROGRAM

 

The eWellness
Distance Monitored Physical Therapy (“DMpt”) program, including: design, testing, exercise intervention, follow-up,
and exercise demonstration, has been developed by accomplished Los Angeles based physical therapist Darwin Fogt. Mr. Fogt has
extensive experience and education working with diverse populations from professional athletes to morbidly obese. He understands
the most beneficial exercise prescription to achieve optimal results and is able to motivate all patient types to stay consistent
in working toward their goals. Additionally, his methods have proven effective and safe as he demonstrates exercises with attention
to proper form to avoid injury.

 

Fogt has
established himself as a national leader in his field and has successfully implemented progressive solutions to delivering physical
therapy. He has bridged the gap between physical therapy and fitness by opening Evolution Fitness, which uses licensed physical
therapists to teach high intensity circuit training fitness classes. He also founded the first exclusive prenatal and postnatal
physical therapy clinic in the country. Mr. Fogt is a leader in advancing the profession to incorporate research-based methods
and focus on, not only rehabilitation but also wellness, functional fitness, performance, and prevention. He is able to recognize
that the national healthcare structure (federal and private insurance) is moving toward a model of prevention.

 

TRACKABLE
PHYSICAL THERAPY

 

The exercise
DMpt prescription and instruction will be delivered with a series of on-line videos easily accessed by each patient on
the internet. Each video will be 30 minutes in length with exercises, which will specifically address the common impairments associated
with diabetes and/or obesity.

 

Exercise
programs will be able to be performed within each patient’s own home or work location without requiring standard gym equipment.

 

Each patient
will be required to log in to the system, Upon conclusion of the prescribed exercise prescription, each successful patient shall
be given the option of continuing to have access to the library of videos for continued independent progression for a nominal
fee.

 

New video
content with exercises specifically designed for the assigned population prescribed and demonstrated by a licensed physical therapist
will be shot to maintain interest in the exercises among the viewing audience with monitoring performed automatically to ensure
their compliance.

 

Each patient
will be required to follow up with their referring physician at designated intervals and metrics such as blood pressure, blood
sugars, BMI, etc. will be recorded to ensure success of the program.

 

    	 

    	 

    

  

TRACKABLE
VIDEO EXERCISE PROGRAM

 

The ON-LINE
DMpt video content will include all aspects of wellness preventative care to ensure the best results: cardiovascular training,
resistance training, flexibility, and balance and stabilization.

 

Research
studies on all the four distinct impairment have proven efficacious. Each video will integrate each of the four components to
guarantee a comprehensive approach to the wellness program, but each video will specifically highlight one of the four components.

 

All of our
DMpt video content will be fully mobile application compliant and are also available on all Desktops, Tablets, PC’s
and MAC computers and devises.

 

Multiple
DMpt exercise videos will be shot to improve adherence to the program and limit redundancy for the patients. Recognizable
athletes and celebrities shall be recruited to participate as subjects in the videos to improve interest for the patients and
improve compliance.

 

SPECIFIC
VIDEO PROGRAMS

 

Each MHC
patient would receive a prescription for a series of three 8-week DMpt courses (24 weeks) in total of physical therapy and exercise
that is provided by viewing on-line programs produced by EWC where the patient can do these exercises and stretching on their
own at least 3-days per week for at least 30 minutes. There would be a total of 8 videos in each DMpt series.

 

The DMpt
videos can be watched on a smart phone, I-pad or desktop. In order to view the videos the patient would log onto the EWC web-site
and would directed to watch the appropriate video in sequence. As they are logged-in, EWC will be able to monitor how often and
if the entire video session was viewed. This data would be captured and every week would be sent the prescribing MHC physician
and EWC physical therapist (“PT”) for review.

 

If the patient
is not viewing the videos, then the prescribing MHC physician and/or the EWC PT would reach out to the patient by telephone and/or
e-mail to encourage the patient to keep up their physical fitness regime. After each series the patient returns for an office
visit to MHC for blood tests, blood pressure and weight management check up as well as a follow-up visit with the physical therapist
for assessment of patient’s progress toward established goals.

 

These DMpt
videos can be watched so that a lot of the instruction and perhaps even biofeedback can be done while walking and being outside
and/or at your office desk.

 

EXERCISE
PATIENT KITS

 

Each patient
shall be provided a home exercise tool kit, which will includes: an inflatable exercise ball, a hand pump, a yoga mat, a yoga
strap, and varying levels of resistance bands.

 

Each of
the DMpt exercise videos will include exercises that incorporate the items given in the tool kit. By using a bare minimum of equipment,
patients should be able to participate more easily at home or at their workplace. The estimated cost of the Exercise patient kit
is $49.99, this amount will be refundable to the patient if they complete the program.

 

Yoga Mats

Yoga Straps

Exercise
Ball

Exercise
Bands: (each patient would get 3 various resist bands) 

Pump

 

    	 

    	 

    

   

UP
HEALTH MONITORING BANDS

 

In conjunction
with the video program each patient would also receive UP Jawbone Health Monitor band. https://jawbone.com/up #system.
Track every move, including to distance, calories burned, active time, sleep time and quality, and activity intensity. The Jawbone
has a price of $99.99 per unit, this amount will be refundable to the patient if they complete the program.

 

UPTM
is a system that takes a holistic approach to a healthy lifestyle. The wristband tracks your movement and sleep in the background.
The app displays your data, lets you add things like meals and mood, and delivers insights that keep you moving forward.

 

UP was designed
to fit seamlessly in people’s lives. Real life. It’s a thoughtful combination of engineering and design, custom-made
for how we live. UP is both flexible and strong. Sometimes UP needs to slide smoothly under sleeves or bend to accommodate an
active lifestyle. Other times it has to be strong enough to stand up to a snowball fight without a problem (or more likely, a
few thousand showers). Day and night, UP is right there with you.

 

iBGSTAR
(For Diabetic Patients Only)

 

In addition
to Jawbone monitoring system and access to exercise videos, patients will receive an iBGStar blood glucose monitoring system.
Data from self-monitoring will be captured and monitored throughout the program.

 

The innovative
iBGStar® is the first blood glucose meter that can be used on its own or connected directly to an Apple iPhone® or iPod
touch® to easily display, manage and communicate your diabetes information. The iBGStar meets today’s industry standards
for accuracy.

 

iBGStar is
anticipated to be reimbursable through insurance submittal with physician prescription, with a cost of $29.99.

 

PATIENT
BILLING

 

Billing
& Reimbursement Cycles: We anticipate that EWC will submit bills to their patients insurance companies on a daily basis.
MHI will charge EWC a fixed billing fee for any services provided.

 

PT Evaluations,
Re-evaluations and Physical tests would be performed by EWC staff that will be located at selected MHC facilities, affiliated
physician offices and non-affiliated physician offices.

 

FOLLOW-ON
PROGRAM

 

Upon conclusion
of the prescribed exercise prescription, each successful patient shall be given the option of continuing to have access to the
library of videos for continued independent progression for a nominal fee of $29.99 for a one-year program extension.

 

New video
content with exercises specifically designed for the assigned population prescribed and demonstrated by a licensed physical therapist
will be shot to maintain interest in the exercises among the viewing audience.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00232-of-00352.parquet"}]]